Insider Transactions in Q1 2021 at Bicycle Therapeutics PLC (BCYC)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$300,000
$30.0 P/Share
|
|
Mar 31
2021
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$80,000
$8.78 P/Share
|
|
Mar 31
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-26.1%
|
$300,000
$30.0 P/Share
|
|
Mar 17
2021
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
7,784
-100.0%
|
$225,736
$29.0 P/Share
|
|
Mar 17
2021
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
7,784
+50.0%
|
$62,272
$8.85 P/Share
|
|
Mar 15
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
217
-0.56%
|
$6,076
$28.0 P/Share
|
|
Mar 12
2021
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
9,783
-10.19%
|
$273,924
$28.74 P/Share
|
|
Mar 12
2021
|
Pierre Legault |
SELL
Open market or private sale
|
Direct |
2,216
-100.0%
|
$64,264
$29.0 P/Share
|
|
Mar 12
2021
|
Pierre Legault |
BUY
Exercise of conversion of derivative security
|
Direct |
2,216
+50.0%
|
$17,728
$8.86 P/Share
|
|
Feb 05
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$3,100
$31.0 P/Share
|
|
Jan 20
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,185
-0.15%
|
$37,920
$32.12 P/Share
|
|
Jan 19
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$450,000
$30.0 P/Share
|
|
Jan 19
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.59 P/Share
|
|
Jan 19
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-0.63%
|
$150,000
$30.15 P/Share
|
|
Jan 15
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-1.85%
|
$135,000
$27.01 P/Share
|
|
Jan 14
2021
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-1.82%
|
$125,000
$25.0 P/Share
|
|
Jan 14
2021
|
Lee Kalowski President and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$250,000
$25.0 P/Share
|
|
Jan 14
2021
|
Lee Kalowski President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$10,000
$1.6 P/Share
|